Optherion

New Haven, CT

Optherion is an early-stage biotechnology company that is developing therapeutics and diagnostic tools for age-related macular degeneration (AMD) and orphan renal diseases strongly influenced by components of the alternative complement system. Optherion's technologies are based on recent genetic discoveries linking certain genes to these disorders.